Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





72nd AACC Annual Scientific Meeting & Clinical Lab Expo Rescheduled to December 13-17, 2020 Due to COVID-19

By LabMedica International staff writers
Posted on 17 Apr 2020
In view of the ongoing spread of COVID-19 across the world and its growing global impact, the American Association for Clinical Chemistry {(AACC) Washington, DC, USA} has decided to reschedule the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo to December in order to ensure a healthy and safe meeting experience for all attendees. More...
The AACC Clinical Lab Expo was originally scheduled to be held July 26-30, 2020 in Chicago, IL, USA.

AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. AACC helps lab professionals adapt to change and provides vital insight and guidance so patients get the care they need. With more than 800 companies exhibiting, the AACC Clinical Lab Expo is the world’s largest exposition for clinical laboratory products and services.

AACC’s leadership has been carefully monitoring the COVID-19 outbreak and consulting members, staff, industry, and other experts. Based on input from all stakeholder groups, and in close collaboration with host city officials, the AACC has announced that it will be able to preserve the complete Annual Scientific Meeting & Clinical Lab Expo experience to which its members, exhibitors, and the entire laboratory medicine community have been looking forward.

The 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will now be held December 13 – 17, 2020 at McCormick Place in Chicago, IL, USA. Rescheduling the event will enable AACC to provide the experience that its attendees and exhibitors expect. The AACC has reaffirmed that the association remains committed to supporting the essential work of laboratory medicine professionals and to holding an event that unites and strengthens the industry in the face of enormous challenges.

Related Links:
American Association for Clinical Chemistry (AACC)


Gold Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.